Literature DB >> 32055945

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China.

Yueying Pan1, Hanxiong Guan1, Shuchang Zhou1, Yujin Wang1, Qian Li1, Tingting Zhu1, Qiongjie Hu2, Liming Xia3.   

Abstract

OBJECTIVES: The purpose of this study was to observe the imaging characteristics of the novel coronavirus pneumonia.
METHODS: Sixty-three confirmed patients were enrolled from December 30, 2019 to January 31, 2020. High-resolution CT (HRCT) of the chest was performed. The number of affected lobes, ground glass nodules (GGO), patchy/punctate ground glass opacities, patchy consolidation, fibrous stripes and irregular solid nodules in each patient's chest CT image were recorded. Additionally, we performed imaging follow-up of these patients.
RESULTS: CT images of 63 confirmed patients were collected. M/F ratio: 33/30. The mean age was 44.9 ± 15.2 years. The mean number of affected lobes was 3.3 ± 1.8. Nineteen (30.2%) patients had one affected lobe, five (7.9%) patients had two affected lobes, four (6.3%) patients had three affected lobes, seven (11.1%) patients had four affected lobes while 28 (44.4%) patients had 5 affected lobes. Fifty-four (85.7%) patients had patchy/punctate ground glass opacities, 14 (22.2%) patients had GGO, 12 (19.0%) patients had patchy consolidation, 11 (17.5%) patients had fibrous stripes and 8 (12.7%) patients had irregular solid nodules. Fifty-four (85.7%) patients progressed, including single GGO increased, enlarged and consolidated; fibrous stripe enlarged, while solid nodules increased and enlarged.
CONCLUSIONS: Imaging changes in novel viral pneumonia are rapid. The manifestations of the novel coronavirus pneumonia are diverse. Imaging changes of typical viral pneumonia and some specific imaging features were observed. Therefore, we need to strengthen the recognition of image changes to help clinicians to diagnose quickly and accurately. KEY POINTS: • High-resolution CT (HRCT) of the chest is critical for early detection, evaluation of disease severity and follow-up of patients with the novel coronavirus pneumonia. • The manifestations of the novel coronavirus pneumonia are diverse and change rapidly. • Radiologists should be aware of the various features of the disease and temporal changes.

Entities:  

Keywords:  Coronavirus infections; Lung diseases; Pneumonia, viral; Thorax; Tomography, x-ray computed

Mesh:

Year:  2020        PMID: 32055945      PMCID: PMC7087663          DOI: 10.1007/s00330-020-06731-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


Introduction

Since December 2019, a number of cases of pneumonia infected with the new coronavirus, i.e. 2019-nCoV, have been found in Wuhan, Hubei province. With the spread of the disease, such cases have also been found in other parts of China and abroad [1]. As of February 2, 2020, there are more than 14,000 confirmed cases and more than 300 deaths. The 2019-nCoV is considered a relative of the deadly severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses. Current study showed that 2019-nCov was more closely related to bat-SL-CoV ZC45 and bat-SL-CoV ZXC21 [2]. Recent studies revealed that 2019-nCoV could spread from human to human, mainly through respiratory droplets, and also through contact [3]. The incubation period is generally 3–7 days, the longest not more than 14 days. Fever, fatigue, and dry cough are the main symptoms. A few patients have symptoms such as nasal congestion, runny nose, and diarrhea. In severe cases, dyspnea occurs more than a week later. In severe cases, acute respiratory distress syndrome, septic shock, difficult to correct metabolic acidosis, and coagulation dysfunction develop rapidly [4]. The confirmed diagnosis of 2019-nCoV infection requires viral nucleic acid detection in throat swabs, sputum, lower respiratory tract secretions, or blood, and the specificity is strong but the sensitivity is poor [5]. According to current experience, lung imaging manifests earlier than clinical symptoms, so imaging examination is vital in preclinical screening. Currently, high-resolution CT (HRCT) is of outstanding importance as it is the main tool for screening, primary diagnosis, and evaluation of disease severity. There are few studies on imaging of 2019-nCoV pneumonia so far. In this study, chest HRCT images of 63 confirmed patients were collected to observe the patients' CT manifestations.

Materials and methods

Population and CT image data acquisition

Sixty-three confirmed patients were enrolled from December 30, 2019 to January 31, 2020. CT (CT HD750 Discovery, GE) examination follows the common chest protocol: the patient is installed in a supine position, arms raised. The patient is instructed to hold their breath during acquisition, that includes whole lung volume. Overall scan time is 2 s, and slice thickness for reconstruction is 1.25 mm.

Qualitative image analysis

The main analysis criteria are the number of affected lobes, presence of ground glass nodules (GGO), patchy/punctate ground glass opacities, patchy consolidation, fibrous stripes, and irregular solid nodules in each patient's chest CT image.

Statistical analysis

Statistical analysis was performed on SPSS 17.0 (IBM Corporation). Measuring data were expressed as mean ± SD.

Results

Demographics

CT images of 63 confirmed patients were collected. M/F ratio: 33/30, mean age was 44.9 ± 15.2 years.

CT images analysis

As shown in Table 1, out of the 63 confirmed patients, the mean number of affected lobes was 3.3 ± 1.8. Nineteen (30.2%) patients had 1 affected lobe, 5 (7.9%) patients had 2 affected lobes, 4 (6.3%) patients had 3 affected lobes, 7 (11.1%) patients had 4 affected lobes, while 28 (44.4%) patients had 5 affected lobes. Fourteen (22.2%) patients had GGO, 54 (85.7%) patients had patchy/punctate ground glass opacities, 12 (19.0%) patients had patchy consolidation, 11 (17.5%) patients had fibrous stripes, and 8 (12.7%) patients had irregular solid nodules. Various lesions were shown in the Fig. 1. We also re-examined CT of these patients with an interval of 3–14 days. It was found that 54 (85.7%) patients progressed, including a single with increasing GGO, enlarged and consolidated, enlarged fibrous stripes, while solid nodules increased and enlarged (Fig. 2).
Table 1

Demographic and lung lesions in HRCT of the included patients. GGO, Ground glass nodule

No.
Number of patients63
Age44.9 ± 15.2 y
M/F33/30
Number of affected lobes3.3 ± 1.8
  Patients number of 1 affected lobe19 (30.2%)
  Patients number of 2 affected lobes5 (7.9%)
  Patients number of 3 affected lobes4 (6.3%)
  Patients number of 4 affected lobes7 (11.1%)
  Patients number of 5 affected lobes28 (44.4%)
Number of GGO14 (22.2%)
Number of patchy/ punctate ground glass opacities54 (85.7%)
Number of patchy consolidation12 (19.0%)
Number of fibrous stripes11 (17.5%)
Number of irregular solid nodules8 (12.7%)
Fig. 1

Various lesions of the included patients. The red arrows and boxes indicated the abnormalities. a, b: GGO; c, d: patchy/punctate ground glass opacities; e, f: patchy consolidation; g: fibrous stripes; h: irregular solid nodules

Fig. 2

Follow up of the new coronavirus pneumonia. a1–d1 are the images of the patients’ first consultation, and a2–d2 are the images of the patients’ re-examination. a1, a2 showed single GGO in one lobe progressed to ground glass patches and consolidation in multi-lobes; b1, b2 showed fibrous stripe in right lower lung progressed to strip; c1, c2 showed solid nodules in right upper lung enlarged; d1 and d2 indicated that the density of solid nodules decreases and the range increases, like “melting sugar”

Demographic and lung lesions in HRCT of the included patients. GGO, Ground glass nodule Various lesions of the included patients. The red arrows and boxes indicated the abnormalities. a, b: GGO; c, d: patchy/punctate ground glass opacities; e, f: patchy consolidation; g: fibrous stripes; h: irregular solid nodules Follow up of the new coronavirus pneumonia. a1–d1 are the images of the patients’ first consultation, and a2–d2 are the images of the patients’ re-examination. a1, a2 showed single GGO in one lobe progressed to ground glass patches and consolidation in multi-lobes; b1, b2 showed fibrous stripe in right lower lung progressed to strip; c1, c2 showed solid nodules in right upper lung enlarged; d1 and d2 indicated that the density of solid nodules decreases and the range increases, like “melting sugar”

Discussion

Coronavirus is a large RNA virus family. Six subtypes have been identified in the past, including SARS and MERS. 2019-nCoV is a new subtype whose genetic structure is 82% similar to SARS-CoV [2]. The source of infection is wild animals, which may be Chinese chrysanthemum head bats or snakes. 2019-nCoV can be transmitted through droplets or contact, and may also be transmitted through the fecal-oral route, with a high incidence and rapid infection, posing a huge threat to global public health [3]. Therefore, detecting the disease accurately and quickly is of great significance. Chest HRCT is an important screening tool for 2019-nCoV due to its high sensitivity and convenience. This study collected 63 confirmed new coronavirus pneumonia patients’ chest CT to analyze their imaging manifestations. The imaging manifestations of the new coronavirus pneumonia are similar to common viral pneumonia, but also have its own imaging characteristics. In our study, patients may have a single lobe or multiple lobes involvement; 30.2% of patients had only one lobe involved, and 44.4% had all lobes involvement. This study shows that the most common manifestations of new coronavirus pneumonia are patchy/punctate ground glass opacities (85.7%), patchy consolidation (19.0%), and mainly distributed in a sub-pleural area (Fig. 1c–f); chest CT of the patients for re-examination after 3–14 days were also observed. It was found that, as the disease progressed, the range of ground glass density patches and consolidation increased (Fig. 2a1, a2), which were mainly distributed in the middle and outer zones of the lung. When patients' condition would improve, a little fibrous stripe may appear. Conversely, when patients' condition worsened, the lungs showed diffuse lesions, and the density of both lungs increased widely, showing a "white lung" appearance, which seriously affects the patient's lung function. It is worth noting that only a single GGO can be seen in some patients at an early stage, and the range significantly increases in the short-term re-examination (Fig. 2a1, a2). In some patients, even if only few fibrous stripes are seen at an early stage, consolidation can develop in the short-term reexamination (Fig. 2b1, b2). In some patients with irregular solid nodules of varying sizes at the early stage, re-examination CT showed that the nodules increased, enlarged, and merged; the density of some solid nodules is reduced, showing a ground glass density, like “melting sugar” (Fig. 2c1–d2). Our observation is that the manifestations of the new coronavirus pneumonia are diverse. Some patients show changes similar to typical viral pneumonia. Some patients have specific imaging features and the patients’ images change rapidly. The purpose of this study is to help early diagnosis based on imaging findings, and to participate in controlling the outbreak by effective countermeasures.
  5 in total

1.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

2.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

3.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 4.  Emerging coronaviruses: Genome structure, replication, and pathogenesis.

Authors:  Yu Chen; Qianyun Liu; Deyin Guo
Journal:  J Med Virol       Date:  2020-02-07       Impact factor: 2.327

  5 in total
  372 in total

1.  Clinical Features of COVID-19 and Factors Associated with Severe Clinical Course: A Systematic Review and Meta-Analysis.

Authors:  Ashish Kumar; Anil Arora; Praveen Sharma; Shrihari Anil Anikhindi; Naresh Bansal; Vikas Singla; Shivam Khare; Abhishyant Srivastava
Journal:  SSRN       Date:  2020-04-21

Review 2.  Déjà vu: Stimulating open drug discovery for SARS-CoV-2.

Authors:  Sean Ekins; Melina Mottin; Paulo R P S Ramos; Bruna K P Sousa; Bruno Junior Neves; Daniel H Foil; Kimberley M Zorn; Rodolpho C Braga; Megan Coffee; Christopher Southan; Ana C Puhl; Carolina Horta Andrade
Journal:  Drug Discov Today       Date:  2020-04-19       Impact factor: 7.851

Review 3.  Radiological approach to COVID-19 pneumonia with an emphasis on chest CT.

Authors:  Serkan Güneyli; Zeynep Atçeken; Hakan Doğan; Emre Altınmakas; Kayhan Çetin Atasoy
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

4.  Utility of chest CT in diagnosis of COVID-19 pneumonia.

Authors:  Ning Luo; Han Zhang; Yang Zhou; ZiXuan Kong; WeiHang Sun; Nan Huang; AoDan Zhang
Journal:  Diagn Interv Radiol       Date:  2020-09       Impact factor: 2.630

5.  Involvement of the Mediastinal Subpleural Pulmonary Parenchyma on Chest CT in COVID-19 patients: A Case Series.

Authors:  Luigi Urciuoli; Elvira Guerriero; Lanfranco Musto
Journal:  J Radiol Case Rep       Date:  2020-11-30

6.  PCR in Sputum for the Diagnosis of COVID-19 in a Case with Infrequent Radiological Pattern.

Authors:  Claudia Janeth Madrid Carbajal; Teresa González Budiño; Marta Iscar Urrutia; Encarnación Nava Tomás; Andrés Ortiz Reyes; Julia Herrero Huertas; Marta García Clemente
Journal:  Arch Bronconeumol       Date:  2020-07-25       Impact factor: 4.872

7.  Blue Lungs in Covid-19 Patients: A Step beyond the Diagnosis of Pulmonary Thromboembolism using MDCT with Iodine Mapping.

Authors:  Virginia Pérez Dueñas; María Allona Krauel; Emilio Agrela Rojas; Maria Teresa Ramírez Prieto; Laura Díez Izquierdo; Ulpiano López de la Guardia; Isabel Torres Sánchez
Journal:  Arch Bronconeumol       Date:  2020-08-28       Impact factor: 4.872

8.  Rehabilitation of post-COVID-19 patients.

Authors:  Mouna Asly; Asmaa Hazim
Journal:  Pan Afr Med J       Date:  2020-07-09

9.  CT imaging of one extended family cluster of corona virus disease 2019 (COVID-19) including adolescent patients and "silent infection".

Authors:  Rui Xu; Mingshan Du; Linfeng Li; Zhiming Zhen; Huiyou Wang; Xiaofei Hu
Journal:  Quant Imaging Med Surg       Date:  2020-03

10.  A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.

Authors:  Taha Yusuf Kuzan; Kübra Murzoğlu Altıntoprak; Hatice Özge Çiftçi; Umut Ergül; Nur Betül Ünal Özdemir; Muhammet Bulut; Nurettin Yiyit
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.